Navigation Links
Terrisca Des Jardins, MHSA, joins my1HIE as Director of Strategic Partnerships
Date:7/22/2009

BINGHAM FARMS, Mich., July 22 /PRNewswire-USNewswire/ -- my1HIE, LLC is excited to introduce Terrisca Des Jardins, MHSA, as the new Director of Strategic Partnerships. Terrisca comes to my1HIE from the Greater Detroit Area Health Council's (GDAHC) Save Lives Save Dollars (SLSD) initiative where she served most recently as Director, SLSD. Terrisca served a lead role in building strategic relationships with key regional, state, national and international organizations to advance the work of SLSD which is now nationally recognized as one of the leading regional collaboratives across the country in accelerating health care reform efforts at a local level. Terrisca provided direction to work areas related to performance measurement and public reporting, differential payment, quality improvement collaboratives, disparities, program assessment and fund development. Among other accomplishments, Terrisca led work on Michigan's first-ever (and one of the first in the country), multi-payer physician organization performance report.

Prior to joining GDAHC in January 2007, Terrisca was an independent consultant for over 5 years. She provided consultation to numerous state and national organizations, foundations, and government agencies. Additionally, during this time, Terrisca provided direction for 4 years to the Southeast Michigan PARTNERS PROJECT, a Centers for Disease Control-sponsored initiative which was awarded the 2004 National Partnership for Immunization Award for its successes in care improvements through multi-stakeholder collaboration.

From 1993 through May of 2001, Terrisca was employed by Health Management Associates as Consultant and then Senior Consultant where her focus of work was on Medicaid and underserved populations where she provided expert consultation to public and private organizations as well as foundations. In her capacity as senior consultant at HMA, Terr
'/>"/>

SOURCE my1HIE
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Richard Greco Joins Mediware Board
2. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
3. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
4. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
5. Nick Childs Joins Grey New York as Director of Content Development
6. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
7. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
8. NASN Joins Partnership to Fight Chronic Disease
9. AstraZeneca Joins Local Walking Movement
10. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
11. Fund Manager Joins Board of GSI Securitization Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4Vivakor Announces New Acquisition Strategy 2Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 1YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 2YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 3YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 4YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 5YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 6U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 1U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 2U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 3New Hampshire Rx Card Launching Statewide 5239 1New Hampshire Rx Card Launching Statewide 5239 2